Insider Trading History of Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended since 2021. This trader's CIK number is 1890904. At the time of last reporting, Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended was the 10% Owner of Better Therapeutics, Inc.. (stock ticker symbol BTTX). Also see all insider trading activities at Better Therapeutics, Inc..


Yearly summary of insider trading at Better Therapeutics, Inc. (BTTX) by Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 BTTX 2,500 $4,922 0 $0 0 $0
2021 BTTX 3,750 $20,738 0 $0 0 $0


Insider trading of Better Therapeutics, Inc. (BTTX) by Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-31 BTTX Buy 2,500 1.97 4,922
2021-12-20 BTTX Buy 1,000 4.60 4,600
2021-12-15 BTTX Buy 750 4.71 3,530
2021-12-10 BTTX Buy 1,000 5.97 5,975
2021-12-03 BTTX Buy 500 6.43 3,213
2021-12-02 BTTX Buy 500 6.84 3,420

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended (10% Owner of Better Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.